In addition to elevated serum ALT and AST levels, treated mice develop mixed micro- and macrovesicular steatosis, ballooning degeneration, Mallory–Denk bodies, and increased collagen deposition associated with hepatic stellate cell activation (Domitrovic et al. 2009). Here, GPT is linked to steatosis.